ERBA Diagnostics Mannheim, GmbH (Erba), a 100 percent subsidiary of Transasia Bio-Medicals Ltd., (Transasia) – India’s leading IVD Company and a recipient of various prestigious National and State level awards acquired a 100 percent stake in Diasis Diagnostik Sistemler Ticaret Ve Sanayi A.S. [Diasis Diagnostic Systems], a reputed company in the field of IVD, headquartered in Istanbul, Turkey. This is the third international acquisition by Erba Diagnostics Mannheim GmbH in a short span of about 16 months. The first being that of a European IVD company, PLIVA-Lachema Diagnostika, s.r.o. [Lachema] based at Czech Republic having a subsidiary in Russia.

The Group already has its presence in over 50 countries through its Distribution and Marketing network. Besides that, Erba-Transasia Group has business alliances with leading IVD companies in the world. Diasis Diagnostic Systems, established in 1993 is involved in the development, production and marketing of products for In Vitro Diagnostics in the field of Biochemistry, Haematology and Urine analysis. It is an ISO 9001/2000 and ISO 13485/2003 certified company and by using its strength in In-House R & D, it has successfully developed over 40 different reagents for Clinical Chemistry and ISE.

Besides enjoying a good reputation and market presence in Turkey over the past 17 years, Diasis Diagnostic Systems has also established an export division which exports its manufactured reagents to several countries including Greece, Bulgaria, Pakistan, India, Bangladesh, Korea etc.

“We regard the acquisition by Erba as a great opportunity for Diasis Diagnostic Systems to aggressively promote the full range of Erba and DDS products in Turkey, Iran, Syria, Azerbaijan and the Turkish speaking Republics”, according to Ruchan Ozatay, Director of Diasis Diagnostic Systems. begin_of_the_skype_highlighting end_of_the_skype_highlighting “Erba’s current customers in Turkey will have better access to quality service through Diasis Diagnostic Systems. The Turkish customers will have access to Erba-Transasia Group’s extensive product range in Clinical Chemistry, Immunoturbidimetry and Immunology products. Added to this the products from Erba’s other group company Lachema in the field of Urine Chemistry, Microbiology and products from IVAX diagnostics in the area of Immunology and Autoimmunity, will strengthen the product offering fromDiasis Diagnostic Systems, which will definitely benefit business partners, customers and patients alike in Turkey,” according to Suresh Vazirani, Chairman of Diasis Diagnostic Systems.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related Corporate Updates


whatsapp--v1